We examined whether deficits in glomerular capillary surface area associated with a congenital nephron deficit could be corrected by glomerular hypertrophy. Using unbiased stereological techniques, we examined the time course and mode of glomerular hypertrophy in mice lacking one allele for glial cell line-derived neurotrophic factor (GDNF). These GDNF heterozygous (Het) mice are born with ϳ30% less nephrons than wild-type (WT) littermates. An additional group of GDNF Het mice received the angiotensin type 1 (AT 1)-receptor antagonist candesartan (Cand; 10 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 ) from 5 wk of age to determine the role of AT 1 receptors in the compensatory hypertrophy. At 10 wk of age, the total volume of renal corpuscles, glomerular capillary surface area, and length of glomerular capillaries in the kidneys of GDNF Het mice were all markedly (ϳ45%) less than that of WT mice (P Ͻ 0.001). However, by 30 wk, and persisting at 60 wk of age, GDNF Het and WT mice did not significantly differ in any of these parameters. Furthermore, conscious 24-h mean arterial pressure (MAP) did not differ between GDNF Het and WT mice at any time point. MAP of GDNF Het-Cand mice was 20 -30 mmHg less than that of GDNF Het-vehicle mice at all three ages, but Cand treatment did not significantly alter glomerular capillary dimensions. In conclusion, we have demonstrated that the deficit in glomerular capillary surface area associated with a congenital nephron deficit can be corrected for in adulthood by an increase in the total length of glomerular capillaries. This process does not require AT 1 receptor activation.
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24-hour blood pressure; nephron endowment; kidney; glomerular capillary surface area; stereology; glomerular hypertrophy THE SURGICAL REDUCTION OF kidney mass in humans and animal models leads to compensatory renal hypertrophy, including glomerular hypertrophy. Glomerular hypertrophy often occurs through the formation of new glomerular capillaries (1, 35) , increasing the total length of capillaries and thus the surface area available for glomerular filtration in the remaining nephrons (1, 2, 35) . However, mesangial cell hyperplasia and hypertrophy, and extracellular matrix expansion can also contribute to the development of glomerular hypertrophy (1, 2) . Thus glomerular volume per se can be a poor indicator of the surface area of glomerular capillaries available for filtration. Congenital reductions in nephron number also lead to compensatory glomerular hypertrophy such that, when examined in adulthood, total glomerular volume (product of total glomerular number and mean glomerular volume) appears normalized in many animal models and humans (10, 17-19, 43, 45) . Although mesangial expansion and glomerulosclerosisis are evident in some models of congenitally reduced nephron endowment (12, 14) , many studies in humans and animals show no evidence of glomerular disease (10, 19, 43, 45) . We hypothesize that deficits in total glomerular capillary length and surface area associated with a congenital nephron deficit can be completely corrected for by glomerular hypertrophy in the absence of the sclerotic process.
Whereas the precise mechanisms driving glomerular hypertrophy are unknown (29) , growth factors such as ANG II are thought to play important roles. ANG II is a potent growth factor for vascular smooth muscle and mesangial cells (44) . The results of studies using chronic angiotensin-converting enzyme inhibition and angiotensin type 1 (AT 1 ) receptor antagonism suggest that ANG II is important in the development of glomerular hypertrophy subsequent to diabetic nephropathy (24) and subtotal nephrectomy (2, 3). Indeed, Adamczak et al.
(1) demonstrated that enalapril treatment not only reduced glomerular hypertrophy following subtotal nephrectomy but also reduced the number and total length of glomerular capillaries. Furthermore, ANG II has also been linked to the normal maturation and growth of glomeruli, independent of blood pressure effects (11) .
The primary aim of the current study was to use unbiased stereological techniques to quantify the lengthening and increase in surface area of glomerular capillaries during development of glomerular hypertrophy in a model of congenital nephron deficit devoid of glomerular disease (9, 10) . Mice lacking one allele for glial cell line-derived neurotrophic factor (GDNF) are born with ϳ30% fewer (9,206 vs. 13,440), but normal-sized, glomeruli compared with wild-type (WT) littermates. However, these GDNF heterozygous (Het) mice develop glomerular hypertrophy, leading to normalization of total glomerular volume in the absence of glomerulosclerosis (9, 10) . In the present study, 10-, 30-, and 60-wk-old GDNF Het and WT littermates were studied to determine the time course of development of glomerular hypertrophy in this model. Our secondary aim was to determine the impact of ANG II (through activation of AT 1 receptors) on this process. Therefore, an additional group of GDNF Het mice was treated chronically with the AT 1 -receptor antagonist candesartan (Cand) cilexetil, from 5 wk of age. Ambulatory (unanesthetized) arterial pressure was measured over a 24-h period in each group of mice at each time point, via a catheter implanted chronically in the carotid artery. (38) . Offspring (8th-13th generation C57BL/6 backcross) were generated from the mating of male GDNF Het mice (129Sv-C57BL/6 hybrid) with female C57BL/6 mice. Tail tissue was obtained at weaning for genotyping (9) . At 5 wk of age, male GDNF Het mice were randomly allocated to receive the AT 1 receptor antagonist Cand cilexetil (10 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 in drinking water; GDNF Het-Cand) or its vehicle (0.1% ethanol-0.1% polyethylene glycol-1.5 mmol/l sodium bicarbonate; GDNF Het-Veh). A third group of male WT mice acting as controls received vehicle (WT-Veh).
METHODS

All
Catheter implantation. At 10, 30, and 60 wk of age, mice were weighed and anesthetized with isoflurane (Forthane, 4 -4.5% vol/vol induction; 1.5-2% vol/vol maintenance; Abbott Australasia, Kurnell, Australia). In brief, mice were surgically instrumented with a carotid artery catheter (ID 0.58 mm, OD 0.96 mm, drawn over heat; SIMS Portex) for direct measurement of arterial pressure and heart rate (HR) and a jugular vein catheter for administration of ANG II at the conclusion of the experiment (see later). Mice received slow infusions of heparinized saline (27 IU/ml, 0.39 l/min; carotid artery) or saline (0.9% wt/vol NaCl, 0.6 l/min; jugular vein) to maintain catheter patency. Pulsatile arterial pressure, recorded continuously for 7 days in conscious mice, was digitized (using a program written in LabView; National Instruments, Austin, TX), and systolic, diastolic, and calculated mean arterial pressure (MAP) and HR were recorded (15, 33) . Circadian rhythms of MAP were restored in both GDNF Het and WT mice by day 4 postsurgery. The difference between daytime and nighttime MAP was similar on days 5 (14.2 Ϯ 1.5 mmHg) and 6 (17.8 Ϯ 4.3 mmHg; P Ͼ 0.05 in all groups at the three ages studied). MAP and HR were averaged for the last 24 h of the recording period (days 6 -7) when circadian rhythms were well established and stable.
Efficiency of AT1 receptor inhibition. At the completion of MAP and HR recording, the efficacy of AT1-receptor antagonism was examined in conscious animals by determining the dose-dependent effects of ANG II on arterial pressure. ANG II was administered intravenously as bolus injections of 0.2, 0.4, 0.8, 1.6, 3.2, and 6.4 nmol/kg. GDNF Het-Cand mice received a further three doses of 12.5, 50, and 100 nmol/kg.
Estimation of total renal corpuscle volume and glomerular capillary surface area and length. Following arterial pressure recordings, mice were anesthetized (pentobarbital sodium; 60 mg/kg iv), and kidneys were perfusion-fixed via the left ventricle using Karnovsky's fixative (2% paraformaldehyde-2% glutaraldehyde, 0.1 M phosphate buffer). Each kidney was decapsulated, weighed, and stored in 10% buffered formalin (10) before estimation of total renal corpuscle volume and glomerular capillary surface area and length using a cascade experimental design (8) .
Estimation of total kidney volume. Left kidneys were sliced transversely at 0.8 mm using a razor blade device, and kidney volume (Vkid) was estimated using the Cavalieri Principle as previously described (41) .
Estimation of the volume density of cortex in the kidney. Every second kidney slice, with a random start, was processed into glycolmethacrylate (GMA; Technovit 7100, Heraeus Kulzer, KG, Germany), and one complete 3-m section was cut from each block and stained with hematoxylin and eosin. Each section was viewed at a final magnification of ϫ24.25 using a microfiche reader fitted with a stereological test grid with an area per point [a(p)] of 1 cm 2 . The volume density of cortex in the kidney (VVcortx,kid) was estimated using:
where Pcortx was the total number of grid points overlying cortex, and Pkid was the total number of grid points overlying kidney.
Estimating the volume density of renal corpuscles in the cortex. Each GMA section was then projected on a computer screen at a final magnification of ϫ600. Using a motorized stage and an orthogonal grid [a(p) of 2.5 cm 2 ], the volume density of renal corpuscles (including glomerulus, urinary space, and parietal epithelium; VVcorp,cortx) in the cortex was estimated using:
where Pcorp was the total number of grid points overlying renal corpuscles.
Estimating the total volume of renal corpuscles in kidney. The total volume of renal corpuscles in kidney (V corp,kid) was estimated using:
Estimating length density and surface area density of capillaries per renal corpuscle. After removing the renal medulla from the remaining slices, the renal cortex was cut into 1 mm ϫ 1 mm pieces of which 10 pieces were randomly collected per kidney. The cortical samples were processed and embedded in epon araldite, and 1-m sections were cut from each of five randomly selected blocks, stained with toludine blue, and viewed at a final magnification of ϫ1,500 using an oil immersion lens and a microscope modified for projection. Glomeruli located less than one glomerular diameter from the section edge were excluded from analysis (20) . From the remaining glomeruli, two were sampled from each section from the five blocks, thus resulting in the analysis of 10 glomeruli/mouse (20) . Glomeruli were selected using the modulus sampling method (36) .
The length density of capillaries in renal corpuscles (length of capillaries/unit volume of renal corpuscle; L Vcap,corp) was estimated using the standard stereological formula:
where 2 is a constant, Q is the number of capillary profiles within renal corpuscle profiles, and a(p) was the area of the grid associated with each point (1 cm 2 ). The surface area density of capillaries per corpuscle (surface area of capillaries/unit volume of renal corpuscle; SVcap,corp) was estimated using methods published previously (20) .
Estimating the total length of glomerular capillaries per kidney. The total length of glomerular capillaries per kidney (L cap,kid) was estimated using the following formula based on a cascade experiment design:
Estimating the total surface area of glomerular capillaries per kidney. The total surface area of glomerular capillaries per kidney (S cap,kid) was estimated using the following formula based on a cascade experimental design:
Estimating the diameter of glomerular capillaries. The mean diameter of glomerular capillaries (dcap) was estimated using the formula:
This estimate is not unbiased since it assumes the capillaries are cylindrical.
Statistics. Values are presented as means Ϯ SE except for stereological data (Fig. 3) , which are presented as means Ϯ SD. ANOVA was performed on all data with factors being age (10, 30, or 60 wk old) and treatment group (WT-Veh, GDNF Het-Veh, or GDNF Het-Cand). These analyses were then partitioned by age, and two sets of specific contrasts were made. Comparisons were made between WT-Veh and GDNF Het-Veh mice, to determine the effects of GDNF haploinsufficiency. Comparisons were also made between GDNF Het-Veh and GDNF Het-Cand mice to determine whether chronic blockade of AT 1 receptors altered the time course of changes in glomerular morphology in GDNF Het mice. P values from these post hoc analyses were conservatively adjusted using the Bonferroni procedure (27) . Lines of best fit were determined by the least-products method (26) . Covariant analysis was performed to determine whether these relationships differed in mice according to age or experimental group (4). Two-tailed PՅ0.05 was considered statistically significant.
RESULTS
MAP and HR in unanesthetized mice. Average 24-h MAP increased with age, and to a similar extent in all three groups (Fig. 1 ). There were no significant differences in MAP between WT-Veh and GDNF Het-Veh mice at any age. However, MAP was 20 -30 mmHg less in GDNF Het-Cand than in GDNF Het-Veh mice at all ages (Fig. 1) . HR was similar in the three groups, but increased significantly with age, to average 452 Ϯ 10, 492 Ϯ 20, and 503 Ϯ 15 beats/min, respectively, at 10, 30, and 60 wk of age (data averaged across the three groups; Fig. 1 ).
Body weight and organ mass. Body weight and kidney mass all increased with age (Table 1) . There was no significant difference in body weight between the WT-Veh and GDNF Het-Veh mice at any age (Table 1) . Both left and right kidneys weighed less in GDNF Het-Veh mice than in WT-Veh mice at 10 wk of age, but by 30 wk of age this difference was only statistically significant for the right kidney. Nevertheless, total kidney weight was less in the GDNF Het-Veh than WT-Veh mice at both 10 and 30 wk of age (Table 1) . At 60 wk of age, kidney weight did not differ significantly between GDNF Het-Veh mice and WT-Veh mice, although kidney-to-body weight ratio was less in the GDNF Het-Veh mice than WT-Veh mice at this time point (Table 1) .
There were no significant differences in body weight or kidney mass between the GDNF Het-Veh and GDNF HetCand mice at any of the ages examined (Table 1) .
Glomerular morphology. The total volume of renal corpuscles per kidney and total glomerular capillary length and surface area increased from 10 to 30 wk of age but remained relatively stable between 30 and 60 wk of age (Fig. 2) . At 10 wk of age, the total volume of renal corpuscles in GDNF Het-Veh kidneys was 33% less than WT-Veh kidneys (Fig. 2) . Total glomerular capillary surface area and length were ϳ45% less in GDNF Het-Veh than WT-Veh mice (Fig. 2) . However, by 30 and 60 wk of age, there was no longer a statistically significant difference in total volume of renal corpuscles or glomerular capillary surface area or length between these two groups. Values for all three parameters were similar in GDNF Het-Cand and GDNF Het-Veh mice at all ages. Glomerular capillary diameter was similar in GDNF Het-Veh and WT-Veh mice at all three ages studied (Fig. 2) . However, an ANOVA of glomerular capillary diameter data detected a statistically significant difference across group (ϭ0.05) and age (ϭ0.02), due mainly to a greater glomerular capillary diameter in the GDNF Het-Cand mice at 10 wk of age (Fig. 2) .
There was a strong linear relationship (r 2 ϭ 0.63) between L cap,kid and the cube root of V corp,kid (Fig. 3A) . This analysis indicates that lengthening of the glomerular capillary vasculature makes a major contribution to the increase in renal corpuscle volume. There was also a weak positive correlation (r 2 ϭ 0.06) between mean glomerular capillary diameter and the cube root of V corp,kid (Fig. 3B) . These relationships were similar in WT-Veh, GDNF Het-Veh, and GDNF Het-Cand mice and at 10, 30, and 60 wk of age.
There was no evidence of renal histopathology (glomerular sclerosis, interstitial fibrosis) in any of the kidneys examined at any age for any group (Fig. 4) .
ANG II dose-response curves. Intravenous ANG II dosedependently increased MAP in all three groups. Responses of WT-Veh and GDNF Het-Veh mice were similar; however, there was a 10-fold rightward shift in the dose-response relationship in GDNF Het-Cand mice.
DISCUSSION
This study provides three major new findings regarding the development of compensatory glomerular hypertrophy in a model of congenital nephron deficit devoid of glomerular disease. First, in young GDNF Het mice before the development of glomerular hypertrophy, a reduced nephron endowment is associated with a deficit in total glomerular capillary Fig. 1 . Twenty-four-hour mean arterial pressure and heart rate of vehicletreated wild-type (WT-Veh), glial cell line-derived neurotrophic factor (GDNF) heterozygous (Het) vehicle (Veh) and candesartan-treated GDNF Het (GDNF Het-Cand) mice at 10 (n ϭ 12, 7, 5), 30 (7, 7, 3) , and 60 (10, 5, 11) wk of age. Data are means Ϯ SE for day 6 after surgery. P values are outcomes of a 2-way ANOVA with the factors group and age. Specific contrasts between WT-Veh-and GDNF Het-Veh-treated mice yielded no significant difference. #P Յ 0.05 and ###P Յ 0.001 for specific contrasts between GDNF Het-Vehand GDNF Het-Cand-treated mice (P values adjusted using the Bonferroni procedure on the basis that 2 comparisons were made at each age).
surface area because of a deficit in total glomerular capillary length. Second, this deficit in total glomerular capillary surface area is normalized by 30 wk of age, mediated chiefly through increased glomerular capillary length. Third, the development of glomerular hypertrophy in GDNF Het mice was unaffected by chronic blockade of AT 1 receptors from 5 wk of age. Our data therefore indicate that the deficits in total glomerular capillary surface area associated with a congenital nephron deficit can be corrected by adulthood through an increase in total glomerular capillary length. Furthermore, the development of compensatory glomerular hypertrophy in this model is not dependent on activation of AT 1 receptors.
A deficit in the functional glomerular filtration capacity has often been inferred in models of congenital nephron deficit simply by the presence of fewer nephrons. However, it is clear from studies in numerous models of congenital nephron defi- Fig. 2 . Total volume of renal corpuscles/kidney (Vcorp,kid), glomerular capillary surface area (Scap,kid), length (Lcap,kid), and average diameter (dcap) of vehicle-treated wild-type (WT-Veh), GDNF Het (GDNF Het-Veh), and candesartan-treated GDNF Het (GDNF Het-Cand) mice at 10 (n ϭ 11, 7, 6), 30 (8, 9, 6) , and 60 (7, 6, 4) wk of age. Data are means Ϯ SD. P values are outcomes of a 2-way ANOVA with the factors group and age. ***P Յ 0.001 for specific contrasts between WT-Veh-and GDNF Het-Veh-treated mice. #P Յ 0.05 for specific contrasts between GDNF Het-Veh-and GDNF Het-Cand-treated mice. Values are group means Ϯ SE. Wt, weight; Veh, vehicle; GDNF, glial cell line-derived neurotrophic factor; Het, heterozygous; Cand, candesartan. P values for age, group, and age ϫ group interaction are the outcomes of 2-way ANOVA. †P Յ 0.05 and *P Յ 0.01 for specific contrasts between wild-type-Veh-and GDNF Het-Veh-treated mice. Specific contrasts between GDNF Het-Veh-and GDNF Het-Cand-treated mice yielded no significant differences. P values for specific contrasts were adjusted using the Bonferroni procedure, on the basis that 2 comparisons were made at each age.
cits and surgical loss of kidney mass that glomeruli undergo some level of hypertrophy over time and that this acts to compensate for the deficiencies in nephron number (1, 10, 43, 46) . Furthermore, unilateral nephrectomy studies consistently demonstrate that the earlier the exposure to the nephron deficit, the greater the capacity of the renal hypertrophic response (6, 22, 35) . Following compensatory glomerular hypertrophy, many animal models of congenital nephron deficit demonstrate a normalization of total glomerular volume in adulthood (10, 43, 45) . We and others have argued that this demonstrates a normalization of capillary surface area (10, 43, 45) . However, in addition to increases in capillary volume, compensatory glomerular hypertrophy can also involve expansion of the mesangium through mesangial cell hypertrophy, hyperplasia, and/or matrix expansion (1, 2, 12, 14) . Thus values obtained for total glomerular volume (product of total glomerular number and mean glomerular volume) may overestimate total glomerular capillary surface area because of the contribution of these noncapillary factors. Therefore, the current study aimed to document the total glomerular capillary length and surface area in GDNF Het mice before the development of glomerular hypertrophy and quantify the change in these parameters with the subsequent development of hypertrophy.
We have previously reported that 30-day-old female GDNF Het mice have 28% fewer but similar-sized glomeruli compared with WT littermates, resulting in a 31% deficit in total glomerular volume (10) . Male mice at this young age show similar characteristics with a 33% deficit in total glomerular volume (unpublished findings). Consistent with these previous findings, the current study demonstrated that, at 10 wk of age, the total volume of renal corpuscles was 33% reduced in kidneys of GDNF Het compared with WT mice. Furthermore, we found that total length and surface area of glomerular capillaries in GDNF Het mice was 45% less than that of WT controls. This 45% deficit in total filtration surface area is greater than would be expected from the 33% reduction in total corpuscle and glomerular volume in young mice. These findings suggest that, even at this early age, differences in the quantity of noncapillary glomerular tissue (e.g., mesangial cells, extracellular matrix) that contributes to the measure of glomerular volume may mask the true extent of deficits in glomerular capillary surface area.
All groups of mice demonstrated age-related increases in mean renal corpuscle volume, total glomerular capillary surface area and length, and mean capillary diameter. The increase in total length of glomerular capillaries was the strongest contributor to mean corpuscle volume. These findings in the mouse are consistent with those of Nyengaard (35) who found that normal glomerular growth in rats occurs via the increase in total length of glomerular capillaries rather than diameter. A striking feature of the glomerular hypertrophic response in the GDNF Het mouse was that it was able to completely correct for the deficit in total glomerular capillary surface area associated with the nephron deficit, mediated chiefly by an increase in total glomerular capillary length rather than diameter. In contrast, neonatal nephrectomy in rats, although followed by significant growth of glomerular capillaries, still results in an overall deficit in glomerular capillary surface area in adulthood (35) . Although not measured in this study, it is likely that the increase in total glomerular capillary length was mediated, as with normal growth, by the formation of new capillary loops rather than the lengthening of existing capillaries (30, 35, 37) . Thus, in the absence of the sclerotic process, congenital reductions in nephron number can be compensated for by an increase in the total length of glomerular capillaries per kidney, which in turn contributes to the development of glomerular hypertrophy.
But why do some animal models of congenital nephron deficit and indeed humans born with fewer nephrons undergo appropriate and corrective compensatory hypertrophy while others develop overt glomerulosclerosis? Recent studies in mice have highlighted genetic background as a critical factor in determining the nature of the glomerular response to congenital or surgically induced nephron deficits (13, 28) . He and colleagues (13) examined the impact of the OS mutation, which induces a 50% congenital deficit in nephron number, on two strains of mice. They found that, although both strains developed similar glomerular hypertrophy at 5 mo of age, ROP mice with the OS mutation developed severe glomerulosclerosis, whereas C57 mice had minimal evidence of glomerulosclerosis (13) . He and colleagues (13) suggested that an imbalance between synthesis and degradation of critical extracellular matrix components may underlie a genetic predisposition to development of sclerosis, whereas others have suggested that the presence of an activated renin-angiotensin system or hypertension may be the key (5, 28) .
Another contributing factor to the development of sclerosis may be the ability of the delicate glomerular capillaries to maintain their structural integrity following the increase in glomerular capillary pressure that occurs subsequent to the loss of nephrons or, as in the case of congenital deficit, as the kidney begins to function ex utero (7, 39) . Nagata et al. (32) found that, following uninephrectomy of young rats, there was a high incidence of enlarged, dilated, and abnormally shaped capillary profiles, and high incidence of focal glomerulosclerosis. Similarly, Haas et al. (12) found that ␣ 8 -integrin-deficient mice, born with 50% fewer glomeruli, demonstrate significant widening of the glomerular capillaries and glomerulosclerosis. It is important to note that the average diameter of glomerular capillaries of GDNF Het and WT mice did not differ at any time point in the present study, nor was there any evidence of abnormal capillary profiles in any of the animals examined.
There is currently no unifying hypothesis as to the mechanisms driving the hypertrophic response to nephron deficiency (29) . ANG II, however, has been implicated in normal glomerular growth and the glomerular hypertrophic response to subtotal nephrectomy and diabetes (1, 2, 11, 24) . Of note, Adamczak et al. (1) found that enalapril treatment reduced the total glomerular capillary surface area, length, and the number of glomerular capillaries in subtotally nephrectomized rats. In contrast to these studies, our current findings provide no evidence for a role of ANG II in the development of compensatory glomerular hypertrophy in the GDNF Het model of congenital nephron deficiency. Cand treatment from 5 wk of age did not impact on the increase in glomerular capillary length or surface area achieved in GDNF Het mice between the 10-and 30-wk time points or on final measures at 60 wk of age. This is despite treatment successfully shifting the ANG II-MAP dose-response curve to the right and reducing MAP by Ͼ20 mmHg at each time point. Our study is not the first to dispute the role of ANG II in glomerular growth using unbiased stereological techniques (31) . Moreover, with similar systemic arterial pressure in GDNF Het-Veh and WT-Veh groups and markedly lower systemic arterial pressure in GDNF Het-Cand mice, it appears that systemic pressure does not contribute to the hypertrophic response. However, measures of glomerular capillary pressure in the three groups by micropuncture techniques are required before dismissing the role for glomerular capillary hydrostatic pressure in the hypertrophic process.
A congenital nephron deficit has been associated with the development of adult hypertension. Indeed, we previously demonstrated that MAP under anesthesia in 14-mo-old GDNFHet mice was 18 mmHg higher than WT littermates (10) . In the current study, arterial pressure was recorded continuously in unanesthetized mice using the indwelling fluid-filled catheter method (23). Although we were able to detect age-related increases in conscious MAP, at no time during the study was the MAP of GDNF Het mice significantly higher than WT littermates. The disparity between our previous (10) and current findings might reflect some underlying prohypertensive factor in aged GDNF Het mice that is uncovered under barbiturate anesthesia. Barbiturate anesthesia blunts cardiovascular reflexes, including those regulating sympathetic vasomotor drive (25) . Importantly, we now conclude that, under controlled laboratory conditions, GDNF Het mice are not hypertensive. At first sight, these observations appear to contradict the wealth of experimental evidence that nephron deficiency predisposes to the development of hypertension (21) . However, recent studies measuring conscious arterial blood pressure in animal models of congenital nephron deficit have shown that the relationship is more complex than initially suggested. Many models of reduced nephron endowment do not develop adult hypertension (47, 16) or demonstrate only minor increases in adult blood pressure when measured directly by telemetry (42) , and it appears it is the presence of a secondary insult (e.g., stress, dietary salt) that unmasks the hypertensive phenotype (34, 42, 47) . Indeed, in a unique human model of reduced nephron endowment, unilateral renal agenesis, only those children with abnormal solitary kidneys (scarring, hydronephrosis) had high blood pressure. Children with healthy solitary kidneys had normal blood pressure (40) . As with the susceptibility to developing glomerulosclerosis, genetic background may also partly determine whether nephron deficiencies lead to hypertension in adulthood. GDNF Het mice are on a C57BL/6 background, and these mice have been previously shown to be resistant to hypertension secondary to 5/6 nephrectomy (28) . Collectively, these observations indicate that the effects of reduced nephron endowment on adult arterial pressure may be conditional on other, yet to be identified, factors.
In conclusion, the GDNF Het mouse, born with ϳ30% fewer glomeruli than WT mice, undergoes compensatory glomerular hypertrophy that normalizes capillary surface area by 30 wk of age. The increase in total glomerular capillary surface area is mediated by an increase in total glomerular capillary length, not capillary diameter. Cand treatment did not impact on total capillary surface area or length of the GDNF Het mice despite markedly lowering systemic arterial pressure, suggesting ANG II is not involved in the compensatory hypertrophic response. In conclusion, we have demonstrated that the reduction in glomerular capillary surface area associated with a congenital nephron deficit can be corrected by adulthood in a model devoid of glomerular disease by a process that is not dependent on AT 1 receptors.
